Skip to main content

Find Clinical Trials

Home
Conditions
Myeloproliferative Chronic Myelomonocytic Leukemia

Clinical trial condition

Myeloproliferative Chronic Myelomonocytic Leukemia

Explore clinical trials studying Myeloproliferative Chronic Myelomonocytic Leukemia. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Myeloproliferative Chronic Myelomonocytic Leukemia trial results

Recruiting

A Phase II Study of Cladribine and Low Dose Cytarabine in Combination With Venetoclax, Alternating With Azacitidine and Venetoclax, in Patients With Higher-risk Myeloproliferative Chronic Myelomonocytic Leukemia or Higher-risk Myelodysplastic Syndromes With Excess Blasts

NCT05365035

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details